21156 ⎘
Medicinal preparations containing antigens or antibodies; Antibodies ; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
Antibodies or fragments thereof directed against a epitope of ISAA or ISAB
#302COMPOSITIONS FOR THE TREATMENT OF HCV AND HBV
#303Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#304Compositions and methods for treating hepatitis virus infection
#305Antibodies to the PcrV antigen of
#306Treatment of celiac disease with IgA
#307Identification and application of antibiotic synergy
#308Human binding molecules having killing activity against enterococci and uses thereof
#309Compositions and methods for the removal of biofilms
#310Monoclonal antibodies that react with the capsule of
#311Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen
#312Vaccine
#313Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells
#314polypeptides and antibodies
#315VMP-like sequences of pathogenic
#316Methods and systems for multi-antibody therapies
#317COMBINATION ANTIBIOTIC AND ANTIBODY THERAPY FOR THE TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION
#318De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
#319Botulinum antitoxin compositions and methods
#320Rationally designed antibodies
#321Vaccine
#322Vaccine
#323Vaccine
#324Vaccine
#325Method or agent for inhibiting the function of efflux pump
#326Antibodies against anthrax protective antigen
#327Antibodies to the PcrV antigen of
#328Human binding molecules having killing activity against enterococci and uses thereof
#329Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#330polypeptides
#331Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells
#332Inhibition of Angiogenesis by Mithramycin
#333Bispecific antibody targeting a complement factor or complement regulatory protein
#334METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY AND DETECTION OF INFLAMMATORY AND IMMUNE-DYSREGULATORY DISEASE, INFECTIOUS DISEASE, PATHOLOGIC ANGIOGENESIS AND CANCER
#335TREATMENT OF MICRO-ORGANISM INFECTION
#336DETECTING TIME PERIODS ASSOCIATED WITH A SURGICAL PROCEDURE
#337DETECTING SURGICAL PHASES AND/OR INTERVENTIONS
#338METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY AND DETECTION OF INFLAMMATORY AND IMMUNE-DYSREGULATORY DISEASE, INFECTIOUS DISEASE, PATHOLOGIC ANGIOGENESIS AND CANCER
#339DETECTING TIME PERIODS ASSOCIATED WITH MEDICAL DEVICE SESSIONS
#340DETECTING TIME PERIODS ASSOCIATED WITH SURGICAL PHASES AND/OR INTERVENTIONS
#341Immunization and treatment methods for anthrax
#342Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
#343Antibodies against protective antigen and methods of use for passive immunization and treatment of anthrax
#344Treatment for bacterial infections
#345Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
#346Compositions and Methods Of Modulating the Immune Response
#347Treatment of micro-organism infection
#348Identification and application of antibiotic synergy
#349VMP-like sequences of pathogenic
#350Antimicrobial activity of antibodies producing reactive oxygen species
#351Neutralizing human antibodies to anthrax toxin
#352Method and compositions for immunotherapy of inflammatory and immune-dysregulatory diseases
#353Anti-HIV composition, production method thereof and medicament
#354Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
#355Colostrum-based composition
#356Optical recording apparatus using one-dimensional diffractive light modulator
#357Treatment of micro-organism infection
#358Botulinum antitoxin compositions and methods
#359Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
#360Method for targeting antigens unique to a tumor